|
1
|
Ruocco E, Ruocco V, Tornesello ML,
Gambardella A, Wolf R and Buonaguro FM: Kaposi's sarcoma: Etiology
and pathogenesis, inducing factors, causal associations, and
treatments: Facts and controversies. Clin Dermatol. 31:413–422.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Schneider JW and Dittmer DP: Diagnosis and
treatment of Kaposi sarcoma. Am J Clin Dermatol. 18:529–539.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lebbe C, Garbe C, Stratigos AJ, Harwood C,
Peris K, Marmol VD, Malvehy J, Zalaudek I, Hoeller C, Dummer R, et
al: Diagnosis and treatment of Kaposi's sarcoma: European
consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J
Cancer. 114:117–127. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Marty M, Sersa G, Garbay JR, Gehl J,
Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D,
et al: Electrochemothrapy, an easy, highly effective and safe
treatment of cutaneous and subcutaneous metastases: Results of
ESOPE (European standard operating procedures of
electrochemotherapy) study. Eur J Cancer Suppl. 4:3–13. 2006.
|
|
5
|
Cadossi R, Ronchetti M and Cadossi M:
Locally enhanced chemotherapy by electroporation: Clinical
experiences and perspective of use of electrochemotherapy. Future
Oncol. 10:877–890. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sersa G, Miklavcic D, Cemazar M, Rudolf Z,
Pucihar G and Snoj M: Electrochemotherapy in treatment of tumours.
Eur J Surg Oncol. 34:232–240. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Esmaeili N and Friebe M:
Electrochemotherapy: A review of current status, alternative IGP
approaches, and future perspectives. J Healthc Eng.
2019(2784516)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cemazar M, Parkins CS, Holder AL, Chaplin
DJ, Tozer GM and Sersa G: Electroporation of human microvascular
endothelial cells: Evidence for an anti-vascular mechanism of
electrochemotherapy. Br J Cancer. 84:565–570. 2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Centre for Reviews and Dissemination,
University of York. PROSPERO: International Prospective Register of
Systematic Reviews. https://www.crd.york.ac.uk/prospero. Accessed October
1, 2019.
|
|
10
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group. Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. J Clin Epidemiol.
62:1006–1012. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Curatolo P, Quaglino P, Marenco F, Mancini
M, Nardò T, Mortera C, Rotunno R, Calvieri S and Bernengo MG:
Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous
lesions: A two-center prospective phase II trial. Ann Surg Oncol.
19:192–198. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Latini A, Bonadies A, Trento E, Bultrini
S, Cota C, Solivetti FM, Ferraro C, Ardigò M, Amorosi B, Palamara
G, et al: Effective treatment of Kaposi's sarcoma by
electrochemotherapy and intravenous bleomycin administration.
Dermatol Ther. 25:214–218. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Starita N, Di Monta G, Cerasuolo A, Marone
U, Anniciello AM, Botti G, Buonaguro L, Buonaguro FM and Tornesello
ML: Effect of electrochemotherapy on human herpesvirus 8 kinetics
in classic Kaposi sarcoma. Infect Agent Cancer.
12(35)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pincus T, Bergman M, Sokka T, Roth J,
Swearingen C and Yazici Y: Visual analog scales in formats other
than a 10 centimeter horizontal line to assess pain and other
clinical data. J Rheumatol. 35:1550–1558. 2008.PubMed/NCBI
|
|
15
|
Stelzer KJ and Griffin TW: A randomized
prospective trial of radiation therapy for AIDS-associated Kaposi's
sarcoma. Int J Radiat Oncol Biol Phys. 27:1057–1061.
1993.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Caccialanza M, Marca S, Piccinno R and
Eulisse G: Radiotherapy of classic and human immunodeficiency
virus-related Kaposi's sarcoma: Results in 1482 lesions. J Eur Acad
Dermatol Venereol. 22:297–302. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hamilton CR, Cumming BJ and Harwood AR:
Radiotherapy of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys.
12:1931–1935. 1986.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fort M, Guet S, Colson-Durand L, Auzolle C
and Belkacemi Y: Role of radiation therapy in non-melanoma cancers,
lymphomas and sarcomas of the skin: Systematic review and best
practice in 2016. Crit Rev Oncol Hematol. 99:200–213.
2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
GLOBOCAN. 2018, Cancer Incidence and
Mortality Worldwide: IARC CancerBase. Lyon, France: International
Agency for Research on Cancer. http://gco.iarc.fr/today/data/factsheets/populations/991-who-africa-region-afro-fact-sheets.pdf.
Accessed April 20, 2020.
|
|
20
|
Boudreaux AA, Smith LL, Cosby CD, Bason
MM, Tappero JW and Berger TG: Intralesional vinblastine for
cutaneous Kaposi's sarcoma associated with acquired
immunodeficiency syndrome. A clinical trial to evaluate efficacy
and discomfort associated with infection. J Am Acad Dermatol.
28:61–65. 1993.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Brambilla L, Bellinvia M, Tourlaki A,
Scoppio B, Gaiani F and Boneschi V: Intralesional vincristine as
first-line therapy for nodular lesions in classic Kaposi sarcoma: A
prospective study in 151 patients. Br J Dermatol. 162:854–859.
2010.PubMed/NCBI View Article : Google Scholar
|
